Introduction
============

Cerebrovascular reactivity (CVR) was defined as the ability of small resistance arteries to constrict or dilate following the change of partial pressures of oxygen or partial pressures of carbon dioxide (PaCO~2~), in which the latter was called CVR to carbon dioxide (CVR-CO~2~).[@b1-tcrm-13-1349] In healthy people, with mean blood pressure (MBP) remaining constant, cerebral blood flow (CBF) increases linearly when PaCO~2~ increases in a specific range, and a study indicates that each 1 mmHg increase in PaCO~2~ leads to an average 2%--4% increase in CBF in healthy people.[@b2-tcrm-13-1349] Thus, CVR-CO~2~ could reflect compensatory vasodilation ability of cerebral small vessels,[@b3-tcrm-13-1349] which was also known as cerebrovascular reserve capacity.

CVR-CO~2~ decrease was related to many diseases, including cerebrovascular diseases,[@b4-tcrm-13-1349]--[@b6-tcrm-13-1349] Alzheimer's disease[@b7-tcrm-13-1349],[@b8-tcrm-13-1349] and hypertension.[@b9-tcrm-13-1349] Cerebrovascular disease has correlation with impaired CVR, and a study shows that reduced CVR was found in patients with lacunar infarct.[@b6-tcrm-13-1349] Another study shows that impaired CVR predicted recurrent symptoms in patients with carotid artery occlusion, and those patients showed a higher risk of recurrent ischemic symptoms.[@b5-tcrm-13-1349] In addition, a study in children with a prior diagnosis of transient cerebral arteriopathy showed that impaired CVR was limited to infarct zone and adjacent white matter in most children.[@b4-tcrm-13-1349] Studies also indicated that CVR-CO~2~ declined in people with Alzheimer's disease, which was characterized by impaired cognitive function.[@b7-tcrm-13-1349],[@b10-tcrm-13-1349],[@b11-tcrm-13-1349] Amyloid-beta peptide accumulation in blood vessels could cause vascular tone dysfunction, which was the main reason of its negative impact on CVR.[@b8-tcrm-13-1349] Galanthamine, which was a commonly used medicine for Alzheimer's disease, could improve patients' CVR.[@b7-tcrm-13-1349]

CVR decrease might also be responsible for impaired cognitive function.[@b12-tcrm-13-1349]--[@b14-tcrm-13-1349] A study shows that CVR was associated with Mini-Mental State Examination (MMSE) scores.[@b12-tcrm-13-1349] Another study shows that after an elderly female patient with mild cognitive dysfunction and decreased CVR endured angioplasty, the CVR and MMSE score improved.[@b14-tcrm-13-1349] In addition, a study showed that vascular impairment in regions of normal-appearing white matter that progressed to white matter hyperintensities (WMHs) consisted of decreased CVR,[@b15-tcrm-13-1349] and WMH was demonstrated to be associated with cognitive decline[@b10-tcrm-13-1349] and dementia.[@b16-tcrm-13-1349]

Thus, the present study aims to investigate the effects of sevoflurane and propofol anesthesia on compensatory vasodilation ability of cerebral small vessels during laparoscopic surgery, and exploring a better anesthetic strategy for patients with impaired cerebrovascular reserve capacity, such as cerebrovascular patients.

Patients and methods
====================

This experimental protocol was approved by Peking University Third Hospital Medical Ethics Committee (Number IRB00006761--2015176), and written informed consent was obtained from the patients. The patients aged in the range of 18--65 years undergoing elective laparoscopic cholecystectomy were enrolled in the study group. Inclusion criteria included physical status of I--II according to the American Society of Anesthesiologists and predicted surgery time of \#2 hours. Exclusion criteria included a history of psychiatric disorder, central nervous system disease, use of sedatives or antipsychotics, preoperative MMSE score \<24 and difficulty in detecting transtemporal window with transcranial Doppler ultrasonic monitor.

Once the patients arrived at the operation room, the needles of Narcotrend (Narcotrend index \[NI\]) were attached to the foreheads, which could analyze electrocardiogram (EEG) and record anesthesia depth. Then, invasive BP, heart rate (HR), EEG and pulse oxymetry (SpO~2~) were monitored and recorded. Before anesthesia induction, a special mask was put on to the patient's face, which connected a separate tube that could be attached to the sampling probe from a capnograph on transcranial Doppler monitor (Multi-Dop X; DWL, Sipplingen, Germany), thereby allowing for end-tidal CO~2~ tension (PetCO~2~) monitoring. When patient was asked to breathe calmly, the expired gas was gathered in an air bag, which was connected to the mask; it was then inhaled by the patient again. The blood stream velocity spectrum of the middle cerebral artery was recorded simultaneously on TCD, including mean (Vmean), maximum (Vmax), minimum (Vmin) blood velocity of middle cerebral artery and pulse index. The data were analyzed with TCD DWL special software. Direct CVR-CO~2~ was defined as the absolute value of blood flow velocity change following each 1 mmHg PetCO~2~ increase (cm/s/mmHg), while relative CVR-CO~2~ (rCVR-CO~2~, which was chosen to record in the present study, hereinafter referred to as CVR-CO~2~) was defined as the blood flow velocity percent change following each 1 mmHg PetCO~2~ increase (%/mmHg), which could be calculated by TCD software.

All patients in the study (n=88) were randomly assigned into sevoflurane group (group S, n=44) or propofol group (group P, n=44). Random sequence was generated by Excel software (2010; Microsoft, Redmond, WA, USA) on the computer. Then some opaque, sealed envelopes received the random number in advance and were opened sequentially, only after the patient's name was written on the appropriate envelope. Different doctors implemented patients' enrolment, assignment and anesthesia management.

During the process, patients who were enrolled were blinded. Then, BP, HR, NI and CVR-CO~2~ were recorded before induction (baseline) in the operation room. In group S, 0.1 μg/kg sulfentanil, 1 mg/kg lidocaine, 2 mg/kg propofol and 0.6 mg/kg rocuronium bromide were applied for induction, and 1.5%--2.5% (end-tidal concentration) sevoflurane with 0.1--1.0 μg/kg/min remifentanil was applied during surgery. In group P, 0.1 μg/kg sulfentanil, 1 mg/kg lidocaine, 0.6 mg/kg rocuronium bromide and 4 μg/mL (in plasma) propofol target-controlled infusion was applied for induction, and 3--4 μg/mL (in plasma) propofol target-controlled infusion with 0.1--1.0 μg/kg/min remifentanil was applied during surgery. NI monitoring was conducted in the patients to maintain an appropriate anesthetic depth during surgery (about stage D0-E1, 64-20) in both groups. After induction, one end of the PetCO~2~ monitoring tube was connected to the endotracheal tube, while the other end was still attached to TCD. Then, respiratory support was provided by mechanical ventilation (volume-controlled ventilation, frequency: 12--20 bpm, tidal volume: 8--10 mL/kg). Then, besides base-line CVR-CO~2~ mentioned above, CVR-CO~2~ was also taken 5 minutes after tracheal intubation (before pneumoperitoneum) and 5 minutes during pneumoperitoneum, respectively. During the process, decreasing tidal volume (6--8 mL/kg) and respiratory frequency (6--10 bpm) were used to increase patients' PetCO~2~ for a short time with SpO~2~ being maintained unchanged.

As mentioned previously, CVR decrease might have correlation with impaired cognitive function.[@b12-tcrm-13-1349]--[@b14-tcrm-13-1349] Therefore, MMSE was tested to evaluate patients' cognitive function before surgery (baseline) and 24 hours after surgery, respectively.

Registration number: ChiCTR-IPR-15007377.

URL: <http://www.chictr.org.cn/showprojen.aspx?proj=12085>.

Statistical analysis
--------------------

The sample size was estimated by the software PASS8.03 (NCSS LLC, Kaysville, UT, USA), and the estimation indicated that 41 patients in group S and 42 patients in group P would be sufficient to detect a difference between CVR-CO~2~ at baseline and that during pneumoperitoneum, respectively. Statistical analysis was performed using SPSS for Windows 22.0 (IBM Corporation, Armonk, NY, USA). The normal distribution test was conducted in quantitative data. The normal distribution data were presented as mean ± SD, and compared using independent-samples *t*-test between groups S and P. The non-normal distribution data were presented as median (first quartile, third quartile), and compared using Mann--Whitney non-parameters tests between groups S and P. The categorical data were presented as frequency and compared using chi-square test. In either group, data taken at baseline, before pneumoperitoneum and during pneumoperitoneum were compared using Wilcoxon signed rank test. Spearman correlation analysis was conducted between MBP and CVR-CO~2~. *P*\<0.05 was considered to be statistically significant in all the tests above.

Results
=======

General information
-------------------

In the present study, 88 patients were enrolled. As illustrated in [Table 1](#t1-tcrm-13-1349){ref-type="table"}, there was no significant difference between the 2 groups in age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA) grade, anesthesia duration and fluid infusion ([Table 1](#t1-tcrm-13-1349){ref-type="table"}, *P*\>0.05).

Cerebrovascular reactivity to carbon dioxide
--------------------------------------------

The values of CVR-CO~2~ at baseline, before pneumoperitoneum and during pneumoperitoneum in either group were compared. As illustrated in [Table 2](#t2-tcrm-13-1349){ref-type="table"}, CVR-CO~2~ before pneumoperitoneum was significantly higher than that at baseline in both groups (*P*\<0.01). During pneumoperitoneum, CVR-CO~2~ was significantly higher than that at baseline only in group S (*P*\<0.05), but not in group P (*P*\>0.05), which means sevoflurane could maintain CVR-CO~2~ at a higher level during pneumoperitoneum, while propofol could not. Therefore, the changing trends of CVR-CO~2~ were also different in the 2 groups during the maintenance phase of anesthesia and pneumoperitoneum.

Mean blood pressure and CVR-CO~2~
---------------------------------

MBP represents the average arterial pressure during a single cardiac cycle.[@b17-tcrm-13-1349] The values of MBP at baseline and before pneumoperitoneum were compared. As illustrated in [Table 3](#t3-tcrm-13-1349){ref-type="table"}, in either group, MBP before pneumoperitoneum was significantly lower than that at baseline (*P*\<0.01), but there was no significant difference between MBP during pneumoperitoneum and at baseline (*P*\>0.05). The changing trends of MBP were the same in both groups.

The correlation indexes (r) between MBP and CVR-CO~2~ are shown below, which indicates that there was no significant correlation between MBP and CVR-CO~2~ (*P*\>0.05, [Table 4](#t4-tcrm-13-1349){ref-type="table"}).

Cognitive function
------------------

As illustrated in [Table 5](#t5-tcrm-13-1349){ref-type="table"}, in either group, there was no significant difference between MMSE scores at baseline and 24 hours after surgery (*P*\>0.05).

Discussion
==========

Laparoscopic surgery is one of the most common surgeries performed in patients of different age groups,[@b18-tcrm-13-1349] and during laparoscopic surgeries, intra-abdominal pressure increase could change hemodynamics and have effects on cerebral circulation.[@b19-tcrm-13-1349] The present study investigated the effects of inhaled anesthetic sevoflurane and intravenous anesthetic propofol on CVR-CO~2~ during laparoscopic surgery and compared the changing trends of CVR-CO~2~ during anesthesia maintenance of the 2 strategies. The results show that in either group, CVR-CO~2~ before pneumoperitoneum was significantly higher than baseline. During pneumoperitoneum, sevoflurane maintained a higher level of CVR-CO~2~ than baseline, but propofol did not, which indicates that 0.5--1.5 MAC sevoflurane could be a better strategy for the patients with decreased CVR-CO~2~ levels (such as cerebrovascular diseases) during laparoscopic surgery. Besides, neither of the 2 anesthesia methods had significant effects on patients' postoperative cognitive function.

A previous study shows that compared with control group, CVR-CO~2~ was preserved in patients who inhaled 1.2 MAC sevoflurane. However, whether CVR-CO~2~ increased or decreased was not observed in that study.[@b20-tcrm-13-1349] In the present study, CVR-CO~2~ increased after induction and maintained at a higher level before and during pneumoperitoneum. The mechanism of that could include the following aspects: First, CVR-CO~2~ is closely related to the function of small vessels in brain. A previous study shows that the effect of anesthetics on CBF depends on the balance of 2 factors. The first factor is the direct vasoconstriction or vasodilation effect of the anesthetic and the second is the indirect vasoconstriction due to the decrease in cerebral metabolic rate of oxygen (CMRO~2~).[@b21-tcrm-13-1349] The direct vasodilation of inhaled anesthetics is stronger than intravenous anesthetic,[@b22-tcrm-13-1349] which makes cerebral-resistant vessels' response to PaCO~2~ more easy. This could partially explain why CVR-CO~2~ during pneumoperitoneum increased compared with baseline in group S. Second, autonomic nervous function is an influence factor in the regulation of CVR-CO~2~.[@b6-tcrm-13-1349] A study shows that the decrease in CVR in patients with lacunar infarct related to the decrease in parasympathetic activity, which could also regulate systemic vascular activity.[@b6-tcrm-13-1349] The parasympathetic activity/sympathetic activity ratio (high frequency/low frequency ratio in measurement of HR variability) increased after induction of general anesthesia and decreased during pneumoperitoneum, and the intra-abdominal pressure could increase sympathetic cardiac activity.[@b23-tcrm-13-1349] In the present study, CVR-CO~2~ increased after anesthesia induction, which might result from the increase in parasympathetic activity/sympathetic activity ratio. Due to the opposite effect of intra-abdominal pressure increase, pneumoperitoneum could decrease CVR-CO~2~. Thus, the higher level of CVR-CO~2~ during pneumoperitoneum in group S should be attributed to the balance of sevoflurane and intra-abdominal pressure, which also indicates that sevoflurane could increase CVR-CO~2~ during laparoscopic surgery. Third, cerebral autoregulation (CA) is defined as a characteristic that CBF changed following BP through vasodilation or vasoconstriction in brain, which reflects contractility of cerebral small vessels. At physiological status, the dilation of cerebral small vessels is the highest when MBP is ≤60 mmHg.[@b24-tcrm-13-1349] A previous study shows that sevoflurane and isoflurane have vasodilatory effects on cerebral artery in patients with spine surgery.[@b25-tcrm-13-1349] In the present study, CVR-CO~2~ increased significantly during anesthesia and pneumoperitoneum without BP change in group S, and there is no significant correlation between CVR-CO~2~ and BP, which indicates that BP and CA may not be the main affecting factors for the CVR-CO~2~ during sevoflurane maintenance.

Propofol was a commonly used intravenous anesthetic. In the present study, it could not maintain a relatively higher level of CVR-CO~2~ during pneumoperitoneum as sevoflurane did, and the underlying mechanism may also include several aspects: First, a study shows that propofol could reduce CMRO~2~ by 35%, which means the indirect vasoconstriction of propofol is stronger than inhaled anesthetics.[@b22-tcrm-13-1349] As a result, the vasoconstriction of propofol could make cerebral-resistant vessels' response to PaCO~2~ harder, and decreases CVR-CO~2~. Second, the increase in intra-abdominal pressure could also decrease CVR-CO~2~ through affecting the parasympathetic activity/sympathetic activity ratio;[@b23-tcrm-13-1349] therefore, the decrease in CVR-CO~2~ during pneumoperitoneum was attributed to the effects of both propofol and intra-abdominal pressure. Third, propofol has been reported to increase the contraction of cerebral-resistant vessels, which means that it could change the adjusting range of CA and the dilation of cerebral-resistant vessels is the highest when MBP is \<90 mmHg.[@b26-tcrm-13-1349] But in the present study, MBP during pneumoperitoneum was maintained at the level of 90 mmHg, which indicates that BP and CA were not the main affecting factors for the CVR-CO~2~ during propofol maintenance.

During the measurement process, the changing range of PetCO~2~ needed to be considered, because the effects of the same anesthetics on CVR-CO~2~ were different at hypercapnia or hypocapnia.[@b22-tcrm-13-1349] Due to the stronger vasoconstriction of propofol, CVR-CO~2~ was not affected apparently by propofol at hypocapnia.[@b22-tcrm-13-1349] On the contrary, CVR-CO~2~ was not affected apparently by high-dose inhaled anesthetics (\>1 MAC) at hypercapnia due to its stronger vasodilation.[@b22-tcrm-13-1349] In this present study, we collected the data at eucapnia (30--40 mmHg PetCO~2~) to calculate CVR-CO~2~, which excluded interference of hypercapnia or hypocapnia.

In the present study, the correlation between BP and CVR-CO~2~ was analyzed. A previous study shows that BP might have effect on CVR-CO~2~.[@b27-tcrm-13-1349] When MBP increased from 80 to 100 mmHg, CVR-CO~2~ in patients under sevoflurane or propofol anesthesia increased significantly.[@b28-tcrm-13-1349] Another animal experiment shows that CVR-CO~2~ was zero when MBP decreased to 40 mmHg.[@b27-tcrm-13-1349] The possible reason was that the dilation of cerebral-resistant vessels was the highest when MBP was less than the lower limit of CA. In this present study, the results show no significant correlation between BP and CVR-CO~2~ at baseline, before pneumoperitoneum and during pneumoperitoneum ([Table 4](#t4-tcrm-13-1349){ref-type="table"}), which indicates that even within physiological range, BP is not the main factor affecting CVR-CO~2~ during laparoscopic surgery.

It has been reported that CVR-CO~2~ correlates with cognitive function,[@b12-tcrm-13-1349]--[@b14-tcrm-13-1349] so the present study also observed the MMSE scores of patients before and after surgery, and the results showed no obvious postoperative cognitive dysfunction with either inhaled or intravenous anesthesia.

Although the study investigated the effect of anesthetics on cerebral circulation and revealed the differences between inhaled and intravenous anesthetics, there are several limitations. First, the surgery durations in the study were short (about 1--2 hours) and the average ages of patients were only 44--45 years. Relatively young patients were enrolled because estimating changing trend of CVR-CO2 during anesthesia needs to exclude other influencing factors, such as advanced age, as much as possible. However, the present study could not provide sufficient evidence to show which anesthetic is better for cognitive function protection. Second, the present study just provided intraoperative CVR-CO2 data, but post-operative data collection and longer follow-up visit would be valuable to reveal patients' long-term prognosis, which needs to be further investigated. Finally, the present study applied intravenous induction in both groups, which may affect the results. Therefore, sevoflurane inhalation induction would be another option in sevoflurane group to exclude the effects of intravenous anesthetic in inhaled anesthetic group.

Conclusion
==========

The present study supplies a possible method to reveal the effect of anesthetics on cerebral circulation, which is direct and convenient. And the results showed that in patients undergoing laparoscopic cholecystectomy, inhaled anesthetic sevoflurane could maintain a higher level of CVR-CO~2~ during anesthesia and pneumoperitoneum stage, while intravenous anesthetic propofol could only maintain a similar level of CVR-CO~2~ with baseline during pneumoperitoneum stage, which indicates that the compensatory vasodilation ability of cerebral small vessels is better during sevoflurane anesthesia. Therefore, in patients with impaired cerebrovascular reserve capacity, such as cerebrovascular disease patients, inhaled anesthetic could be a priority strategy for anesthesia maintenance to improve the compensatory vasodilation ability of cerebral small vessels during surgery.
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###### 

Characteristics of patients

  Variables                   Sevoflurane group (n=44)   Propofol group (n=44)   *P*-value
  --------------------------- -------------------------- ----------------------- -----------
  Age (years)                 45.07±12.12                44.20±12.87             0.353
  Sex (M/F)                   22/22                      21/23                   0.831
  BMI (kg/m^2^)               24.64±3.75                 24.28±3.17              0.220
  ASA grade (I/II)            34/10                      35/9                    0.796
  Anesthesia duration (min)   65.05±7.05                 66.40±4.60              0.750
  Fluid infusion (mL)         500.65±276.93              500.74±280.05           0.643

**Note:** Data presented as mean ± SD.

**Abbreviations:** M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologists.

###### 

CVR-CO~2~ before and during pneumoperitoneum compared with baseline

  Group                      Baseline            Before pneumoperitoneum                                            During pneumoperitoneum
  -------------------------- ------------------- ------------------------------------------------------------------ ----------------------------------------------------------------
  Sevoflurane group (n=44)   3.76 (2.56, 5.07)   4.63 (3.59, 6.95)[\*\*](#tfn5-tcrm-13-1349){ref-type="table-fn"}   4.29 (2.98, 6.32)[\*](#tfn4-tcrm-13-1349){ref-type="table-fn"}
  Propofol group (n=44)      4.04 (2.97, 5.09)   4.67 (3.56, 6.12)[\*](#tfn4-tcrm-13-1349){ref-type="table-fn"}     3.91 (3.47, 6.00)

**Notes:** Data presented as median (first quartile, third quartile); the unit of Vmean-CO~2~ is %/mmHg.

*P*\<0.05,

*P*\<0.01 in comparison with baseline.

**Abbreviation:** CVR-CO~2~, cerebrovascular reactivity to carbon dioxide.

###### 

MBP before and during pneumoperitoneum compared with baseline

  Group                      Baseline      Before pneumoperitoneum                                      During pneumoperitoneum
  -------------------------- ------------- ------------------------------------------------------------ -------------------------
  Sevoflurane group (n=44)   85 (90, 93)   78 (71, 84)[\*\*](#tfn8-tcrm-13-1349){ref-type="table-fn"}   85 (77, 93)
  Propofol group (n=44)      88 (81, 98)   79 (73, 89)[\*\*](#tfn8-tcrm-13-1349){ref-type="table-fn"}   90 (84, 97)

**Notes:** Data presented as median (first quartile, third quartile); the unit of MBP is mmHg.

*P*\<0.01 in comparison with baseline.

**Abbreviation:** MBP, mean blood pressure.

###### 

Correlations between MBP and CVR-CO~2~

  Group                      Baseline   Before pneumoperitoneum   During pneumoperitoneum
  -------------------------- ---------- ------------------------- -------------------------
  Sevoflurane group (n=44)   −0.009     −0.014                    0.017
  Propofol group (n=44)      0.036      0.095                     −0.044

**Abbreviations:** CVR-CO~2~, cerebrovascular reactivity to carbon dioxide; MBP, mean blood pressure.

###### 

Comparisons of MMSE scores at different time points

  Group                      Baseline      24 hours after surgery
  -------------------------- ------------- ------------------------
  Sevoflurane group (n=44)   29 (28, 29)   28 (28, 29)
  Propofol group (n=44)      28 (28, 29)   28 (27, 29)

**Note:** Data presented as median (first quartile, third quartile).

**Abbreviation:** MMSE, Mini-Mental State Examination.
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